AstraZeneca has announced the loss of 1,400 jobs in its European manufacturing and supply chain infrastructure.The company says the introduction …
Plans to make Viagra available through pharmacies in Europe without a prescription have been scuppered by safety concerns.Pfizer has ended …
Boehringer Ingelheim's new lung cancer drug Vargatef has entered phase III trials.The drug is part of the manufacturer's burgeoning oncology …
Initiatives to make the UK a world class location for medical research needs significant pharma input to be a success, …
A key NHS reform isn't working and requires a major overhaul, according to a new report by think tank The …
The UK government has agreed a new flexible pricing deal with the industry, in which companies can raise the price …
Pfizer has launched a global stem cell research unit to develop a new generation of medicines.The research unit, to be …
You probably know the type: successful people who apparently ease through their careers, seemingly running on invisible, smooth rails towards …
Targeted cancer drugs like Herceptin and Glivec have greatly improved pharma's oncology pipeline success rates, according to a new study. …
Pharmaceutical companies are increasingly looking to 'managed entry' programmes to build strong relationships with NHS customers and ensure new products …
Key decision makers will shape the biosimilars landscapeWith many biologic drugs used to treat increasingly common diseases such as cancer …
NICE is set to recommend Roche's lung cancer treatment Tarceva after the company agreed to lower the drug's price. The …
More exercise and healthier eating are at the core of the government's new anti-obesity initiative, called Change4Life. Billed this week …
GlaxoSmithKline has announced plans to close its manufacturing site in Dartford in the UK, with operations being phased out over …
AstraZeneca's statin Crestor made national headlines this week when it was shown to dramatically reduce major cardiovascular events. New data …
GlaxoSmithKline has withdrawn the US application for its restless legs syndrome treatment Solzira. The company, along with co-developer XenoPort, is …
The government is working with the pharma industry on new 'flexible pricing' arrangements, even though revisions to the existing PPRS …
Results from clinical trials are the very lifeblood of the pharmaceutical industry, representing the frontline in the search for new …
MedImmune, AstraZeneca's biotech arm, has opened a new R&D facility in Cambridge as part of a major expansion of its …
PCTs will have to make major and unplanned cuts to their drugs budgets and divert the money to shore up …